Evidence mapPaperPMID 42246940Full record

ReviewThe Journal of physiology2026

Experimental models of cerebral small vessel disease: Physiological constraints, translational challenges and future directions.

Sophie Beaumont, Tanya Singh, Luana Campos Soares, Mootaz M Salman

Abstract readReview
In one paragraph

Review in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sophie BeaumontDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK.ORCID https://orcid.org/0009-0005-7426-9445
Tanya SinghDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK.
Luana Campos SoaresDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK.
Mootaz M SalmanDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-5683-1706

Funding

BHF Centre of Research ExcellenceBritish Heart FoundationBritish Heart Foundation (BHF)Medical Research CouncilMedical Research Council Career Development Award MR/W027119/1UK Dementia Research Institute UK DRI-8203UK DRI LtdUniversity of Oxford RE/24/130024
6 · The paper itself

Abstract

Cerebral small vessel disease (cSVD) is a chronic, progressive cerebrovascular disorder and the second most common cause of dementia after Alzheimer's disease. It accounts for approximately 20% of strokes, including a quarter of ischaemic strokes and nearly half of vascular dementias, representing a growing clinical and socio-economic burden in ageing populations. Despite its prevalence, mechanistic understanding remains limited and disease-modifying therapies are lacking. A major obstacle is the difficulty of interrogating disease progression in vivo, as the small calibre and deep location of affected vessels restrict assessment. Experimental modelling has therefore been central to advancing cSVD research. Rodent models have provided insight into vascular dysfunction, white matter injury and blood-brain barrier (BBB) impairment, but differ from humans in cerebrovascular anatomy, cellular composition and disease trajectory. Emerging in vitro approaches, including three-dimensional cultures and microfluidic systems incorporating human vascular cells, offer improved experimental control and translational relevance, yet struggle to capture the slow progression of cSVD and its comorbidities such as hypertension and ageing. Most models therefore isolate pathological features rather than reproducing the integrated physiology of disease. In this review, we critically evaluate current in vivo, in vitro and in silico models of cSVD, highlighting their strengths and limitations. We identify the glymphatic system and brain clearance as underexplored but potentially unifying pathways linking vascular dysfunction, perivascular-space enlargement and impaired fluid clearance. Incorporating glymphatic elements into advanced models may address key mechanistic gaps. Improving physiological fidelity in cSVD modelling will be essential for robust target identification and development of effective therapies.

Indexed as

Cerebral Small Vessel DiseasesAnimalsBlood-Brain BarrierDisease Models, AnimalHumansAQP4BBBbrain clearancecerebral small vessel diseaseglymphatic systemneurovascular unitSVD

Identifiers

PMID42246940
PMCPMC13370708

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.